Towards automation of breast cancer screening

Matthieu Leclerc-Chalvet
Pierre Fillard

Elaia Team

Laurent Kott

Related articles

The Company will accelerate the commercial deployment of its Artificial Intelligence reading solution for 2D/3D mammography, with a focus on the United States 

2022.05.12 / 3min read.

MammoScreenTM, the explainable and actionable artificial intelligence (AI) based software assisting Radiologists in reading screening mammograms, received 510(k) clearance K192854 from the U.S. Food and Drug Administration (FDA).

2020.07.09 / 3min read.